NORCO tablets (Hydrocodone Bitartrate/Acetaminophen 10 mg/325 mg)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Watson Pharmaceuticals
Approval Status: Approved February 1997
Treatment Area: moderate pain

General Information

NORCO tablets (Hydrocodone Bitartrate/Acetaminophen 10 mg/325 mg) have been approved for the treatment of moderate pain. NORCO is the highest single tablet dose of Hydrocodone Bitartrate with the lowest level of Acetaminophen of all 10 mg Hydrocodone combination products indicated for the relief of moderate to moderately severe pain.

Get Involved

Stroke and You

Stay Informed

Resources

Our Mission Statement

National Stroke Association’s mission is to reduce the incidence and impact of stroke by developing compelling education and programs focused on prevention, treatment, rehabilitation and support for all impacted by stroke.

Visit Our Online Store

National Stroke Association

1-800-STROKES
1-800-787-6537
9707 E. Easter Lane, Suite B
Centennial, CO 80112
info@stroke.org

Clinical Trials Resource Center